174 related articles for article (PubMed ID: 37679753)
1. Healthcare provider and drug dispenser knowledge and adherence to guidelines for the case management of malaria in pregnancy in the context of multiple first-line artemisinin-based combination therapy in western Kenya.
Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile F; Gutman JR; Hill J
Malar J; 2023 Sep; 22(1):262. PubMed ID: 37679753
[TBL] [Abstract][Full Text] [Related]
2. Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.
Osoro CB; Dellicour S; Ochodo E; Young T; Ter Kuile FO; Gutman JR; Hill J
Malar J; 2023 Sep; 22(1):274. PubMed ID: 37710229
[TBL] [Abstract][Full Text] [Related]
3. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
Watsierah CA; Onyango RO; Ombaka JH; Abong'o BO; Ouma C
Malar J; 2012 Dec; 11():436. PubMed ID: 23273046
[TBL] [Abstract][Full Text] [Related]
4. Knowledge and Adherence to the National Guidelines for Malaria Case Management in Pregnancy among Healthcare Providers and Drug Outlet Dispensers in Rural, Western Kenya.
Riley C; Dellicour S; Ouma P; Kioko U; ter Kuile FO; Omar A; Kariuki S; Buff AM; Desai M; Gutman J
PLoS One; 2016; 11(1):e0145616. PubMed ID: 26789638
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
Saito M; McGready R; Tinto H; Rouamba T; Mosha D; Rulisa S; Kariuki S; Desai M; Manyando C; Njunju EM; Sevene E; Vala A; Augusto O; Clerk C; Were E; Mrema S; Kisinza W; Byamugisha J; Kagawa M; Singlovic J; Yore M; van Eijk AM; Mehta U; Stergachis A; Hill J; Stepniewska K; Gomes M; Guérin PJ; Nosten F; Ter Kuile FO; Dellicour S
Lancet; 2023 Jan; 401(10371):118-130. PubMed ID: 36442488
[TBL] [Abstract][Full Text] [Related]
6. Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya.
Watsierah CA; Ouma C
Malar J; 2014 Jul; 13():290. PubMed ID: 25066600
[TBL] [Abstract][Full Text] [Related]
7. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
8. First trimester use of artemisinin-based combination therapy and the risk of low birth weight and small for gestational age.
Augusto O; Stergachis A; Dellicour S; Tinto H; Valá A; Ruperez M; Macete E; Nakanabo-Diallo S; Kazienga A; Valéa I; d'Alessandro U; Ter Kuile FO; Calip GS; Ouma P; Desai M; Sevene E
Malar J; 2020 Apr; 19(1):144. PubMed ID: 32268901
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.
Obonyo CO; Juma EA; Were VO; Ogutu BR
Malar J; 2022 Feb; 21(1):30. PubMed ID: 35109841
[TBL] [Abstract][Full Text] [Related]
10. Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso.
Hien D; Kaboré JMT; Siribié M; Soulama I; Barry N; Baguiya A; Tiono AB; Tchouatieu AM; Sirima SB
Malar J; 2022 Jun; 21(1):202. PubMed ID: 35761273
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
Al Khaja KAJ; Sequeira RP
Malar J; 2021 Jan; 20(1):62. PubMed ID: 33485330
[TBL] [Abstract][Full Text] [Related]
12. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.
Manyando C; Kayentao K; D'Alessandro U; Okafor HU; Juma E; Hamed K
Malar J; 2012 May; 11():141. PubMed ID: 22548983
[TBL] [Abstract][Full Text] [Related]
14. Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.
Young N; Taegtmeyer M; Aol G; Bigogo GM; Phillips-Howard PA; Hill J; Laserson KF; Ter Kuile F; Desai M
PLoS One; 2018; 13(7):e0198784. PubMed ID: 30028852
[TBL] [Abstract][Full Text] [Related]
15. Adherence to national guidelines for the diagnosis and management of severe malaria: a nationwide, cross-sectional survey in Malawi, 2012.
Shah MP; Briggs-Hagen M; Chinkhumba J; Bauleni A; Chalira A; Moyo D; Dodoli W; Luhanga M; Sande J; Ali D; Gutman J; Mathanga DP; Lindblade KA
Malar J; 2016 Jul; 15(1):369. PubMed ID: 27430311
[TBL] [Abstract][Full Text] [Related]
16. Anti-malarial drug use, appropriateness and associated factors among children under-five with febrile illnesses presenting to a tertiary health facility: a cross sectional study.
Nyeko R; Otim F; Obiya EM; Abala C
Malar J; 2023 Mar; 22(1):103. PubMed ID: 36941616
[TBL] [Abstract][Full Text] [Related]
17. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
McGready R; Tan SO; Ashley EA; Pimanpanarak M; Viladpai-Nguen J; Phaiphun L; Wüstefeld K; Barends M; Laochan N; Keereecharoen L; Lindegardh N; Singhasivanon P; White NJ; Nosten F
PLoS Med; 2008 Dec; 5(12):e253. PubMed ID: 19265453
[TBL] [Abstract][Full Text] [Related]
18. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
[TBL] [Abstract][Full Text] [Related]
19. Adherence to national malaria treatment guidelines in private drug outlets: a cross-sectional survey in the malaria-endemic Kisumu County, Kenya.
Odhiambo FO; O'Meara WP; Abade A; Owiny M; Odhiambo F; Oyugi EO
Malar J; 2023 Oct; 22(1):307. PubMed ID: 37821868
[TBL] [Abstract][Full Text] [Related]
20. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
